Observational Study
Copyright ©The Author(s) 2016.
World J Gastroenterol. May 21, 2016; 22(19): 4757-4765
Published online May 21, 2016. doi: 10.3748/wjg.v22.i19.4757
Figure 1
Figure 1 Physicians’ awareness of fecal microbiota transplantation in different regions. FMT: Fecal microbiota transplantation.
Figure 2
Figure 2 Physicians’ acceptance of fecal microbiota transplantation in different regions.
Figure 3
Figure 3 Physicians’ concerns about choosing fecal microbiota transplantation as a treatment.
Figure 4
Figure 4 Barriers against clinical applications of fecal microbiota transplantation.
Figure 5
Figure 5 Fecal microbiota transplantation indications. RCDI: Refractory Clostridium difficile infection; UC: Ulcerative colitis; CD: Crohn’s Disease; RUC: Refractory ulcerative colitis; CDI-IBD: Inflammatory bowel disease with Clostridium difficile infection; IBS: Irritable bowel syndrome; 2-DM: Type 2 diabetes mellitus.
Figure 6
Figure 6 Selection of donors.
Figure 7
Figure 7 Reasons for lower gastrointestinal tract selection.
Figure 8
Figure 8 Physicians’ perceptions of fecal microbiota transplantation risk.